Continuous CD8 + T-cell priming by dendritic cell cross-presentation of persistent antigen following adeno-associated virus-mediated gene delivery

Journal of Virology

Volumn 85, Issue 22, 2011, Pages 12083-12086

  Xu, Dan ^a,b   Walker, Christopher M ^a,b  

^a THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; PLASMID DNA; ANTIGEN; BETA GALACTOSIDASE; BRACHYURY PROTEIN; FETOPROTEIN; T BOX TRANSCRIPTION FACTOR;

ADENO ASSOCIATED VIRUS; ANIMAL CELL; ANTIGEN PRESENTATION; BONE MARROW; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CROSS PRESENTATION; DENDRITIC CELL; GENE DELIVERY SYSTEM; IRRADIATION; MEMBRANE RECONSTITUTION; NONHUMAN; NOTE; PRIORITY JOURNAL; SKELETAL MUSCLE; T LYMPHOCYTE; VIRAL GENE DELIVERY SYSTEM; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; C57BL MOUSE; GENE; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; IMMUNOLOGY; MOUSE;

ADENO-ASSOCIATED VIRUS; MUS;

ANIMALS; ANTIGENS; BETA-GALACTOSIDASE; CD8-POSITIVE T-LYMPHOCYTES; CROSS-PRIMING; DENDRITIC CELLS; DEPENDOVIRUS; FETAL PROTEINS; GENES; GENETIC VECTORS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; T-BOX DOMAIN PROTEINS; TRANSDUCTION, GENETIC;

EID: 80655142485     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.05375-11     Document Type: Note

References (17)

1. + T-cell expansion and maintenance after recombinant adenovirus immunization rely upon cooperation between hematopoietic and nonhematopoietic antigen-presenting cells. Blood 117: 1146-1155.
2. Cordier, L., et al. 2001. Muscle-specific promoters may be necessary for adeno-associated virus-mediated gene transfer in the treatment of muscular dystrophies. Hum. Gene Ther. 12:205-215.
3. Corr, M., D. J. Lee, D. A. Carson, and H. Tighe. 1996. Gene vaccination with naked plasmid DNA: mechanism of CTL priming. J. Exp. Med. 184:1555-1560.
4. Doe, B., M. Selby, S. Barnett, J. Baenziger, and C. M. Walker. 1996. Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells. Proc. Natl. Acad. Sci. U. S. A. 93:8578-8583.
5. Fu, T. M., et al. 1997. Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes. Mol. Med. 3:362-371.
6. Jooss, K., Y. Yang, K. J. Fisher, and J. M. Wilson. 1998. Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers. J. Virol. 72:4212-4223.
7. Li, C., et al. 2007. Adeno-associated virus type 2 (AAV2) capsid-specific cytotoxic T lymphocytes eliminate only vector-transduced cells coexpressing the AAV2 capsid in vivo. J. Virol. 81:7540-7547.
8. + T-cell responses in mice. J. Virol. 81:11840-11849.
9. + T cells in mice. J. Clin. Invest. 117:3958-3970.
10. Lu, Y., and S. Song. 2009. Distinct immune responses to transgene products from rAAV1 and rAAV8 vectors. Proc. Natl. Acad. Sci. U. S. A. 106:17158-17162.
11. + T cell response to vector encoded proteins. J. Immunol. 182:6051-6060.
12. Mays, L. E., and J. M. Wilson. 2011. The complex and evolving story of T cell activation to AAV vector-encoded transgene products. Mol. Ther. 19:16-27.
13. Vandenberghe, L. H., et al. 2006. Heparin binding directs activation of T cells against adeno-associated virus serotype 2 capsid. Nat. Med. 12:967-971.
14. Velazquez, V. M., D. G. Bowen, and C. M. Walker. 2009. Silencing of T lymphocytes by antigen-driven programmed death in recombinant adenoassociated virus vector-mediated gene therapy. Blood 113:538-545.
15. Xin, K.-Q., et al. 2006. Induction of robust immune responses against human immunodeficiency virus is supported by the inherent tropism of adenoassociated virus type 5 for dendritic cells. J. Virol. 80:11899-11910.
16. Zhang, Y., N. Chirmule, G.-P. Gao, and J. Wilson. 2000. CD40 liganddependent activation of cytotoxic T lymphocytes by adeno-associated virus vectors in vivo: role of immature dendritic cells. J. Virol. 74:8003-8010.
17. Ziegler, R. J., et al. 2004. AAV2 vector harboring a liver-restricted promoter facilitates sustained expression of therapeutic levels of alpha-galactosidase A and the induction of immune tolerance in Fabry mice. Mol. Ther. 9:231-240.